Managing Risk for Clinical Trials

Webinar Details

whenWhen?  Tuesday, Sept. 9, 2014
whereWhere? Your Office
whenTime?   1:30 p.m. - 3:00 p.m. EDT

Register

Webinar plus Audio CD/Transcript $487
Webinar only $287
24/7 Encore plus CD/Transcript $487
24/7 Encore Presentation $287
Audio CD/Transcript $287

Download the presentation materials here.

Managing Risk for Clinical Trials
Incorporating Quality by Design and Risk Management Strategies

Among the many issues that can derail a clinical trial, quality failures are surely the most frustrating.

Why? Because risk management techniques exist that can help you detect and mitigate the risks that can lead to clinical trial failures.

Those undetected flaws in your design and development process are preventable if, early in a trial, you incorporate risk management strategies such as Risk Management Plans and Quality by Design (QbD) tools.

The real question is: What are you waiting for?

On Sept. 9, the FDAnews webinar Managing Risk for Clinical Trials: Incorporating Quality by Design and Risk Management Strategies will help you make that critical choice.

With more than 50 years of combined experience, expert presenters Sherri Hubby and Brian Nugent will share insights that can be used to establish Risk Based Monitoring Plans, including triggers for return to 100% source data verification. 

Even better, they'll show you how to proactively identify and manage risks to your trial with methods that can immediately be implemented and used.

You'll find out about QbD examples such as failure-modes-and-effects and criticality analysis (FMECA), Isikawa/Fishbone Diagrams, and Hazard Analysis and Critical Control Points (HACCPs).

 And you'll learn these specifics:

  • 10 factors to consider when evaluating risk-based monitoring for clinical trials
  • 6 triggers for moving from on-site monitoring to centralized monitoring
  • 7 warning signals that suggest increased source data verification is needed at an investigator site
  • 6 elements of a site level risk-based monitoring plan
  • Best practices from successful programs that are actively using centralized risk-based monitoring
  • The "5 why" approach to prospectively identifying the root cause of a non-compliance systemic issue
  • Tips for establishing an effective risk management system culture within your organization
  • And more!

BONUS: During the session, you'll also receive a copy of an invaluable risk assessment process/checklist to apply to your selection of vendors.

Attending Managing Risk for Clinical Trials: Incorporating Quality by Design and Risk Management Strategies might be the best decision you make in 2014.

After all, Risk Management Quality by Design (QbD) Strategies are encouraged by regulators such as the FDA and EMA.  In fact, the QbD process was first introduced by the FDA — and is considered an important process and systematic approach to achieve clinical success.

Don't stop to think about it; register NOW.